Schizophrenia Research
Volume 41, Issue 3 , Pages 405-415, 14 February 2000

Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene?

  • Vibeke Sørensen Catts

      Affiliations

    • Schizophrenia Research Unit, South Western Sydney Area Health Service, Don Everett Building, Liverpool Hospital, PO Box 103, Liverpool, NSW 2170, Australia
  • ,
  • Stanley Victor Catts

      Affiliations

    • School of Psychiatry, University of New South Wales, Sydney, NSW 2052, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61-2-9828-6182; fax: +61-2-9828-6181

Received 9 December 1998; accepted 16 April 1999.

Abstract 

This paper reviews the six published incidence studies of the relative risk of cancer in patients with schizophrenia compared with the general population. These studies used: incidence data, register case ascertainment, and controlled for age and sex. It is concluded that schizophrenia is associated with a lower risk of developing cancer. The role of apoptosis (programmed cell death) in cancer and brain development is briefly described. The possibility is explored that increased apoptosis may account for neurodevelopmental abnormalities as well as tumour resistance associated with schizophrenia. The authors propose that p53, a tumour suppressor gene central to regulation of apoptosis, should be investigated as a candidate susceptibility gene in schizophrenia.

Keywords: Apoptosis, Cancer, Candidate gene, p53, Schizophrenia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0920-9964(99)00077-8

Schizophrenia Research
Volume 41, Issue 3 , Pages 405-415, 14 February 2000